KALEIDO BIOSCIENCES, INC. Financing Cash Flow
KALEIDO BIOSCIENCES, INC. reported Financing Cash Flow of $70.04 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was -$25.00K, a 100.69% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was -$14.00K, a 100.98% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was -$68.00K, a 100.20% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $70.14M, a 4457.76% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2021 was $70.04M, a 73.36% increase from fiscal 2020.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2020 was $40.40M, a 45.88% decline from fiscal 2019.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2019 was $74.64M, a 24.53% decline from fiscal 2018.
- KALEIDO BIOSCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2018 was $98.91M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | -$39.00K derived: sum of 2 quarters · filed 2022-04-01 | -$107.00K derived: sum of 3 quarters · filed 2022-04-01 | $70.04M 10-K · filed 2022-04-01 |
| 2021-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$82.00K derived: sum of 2 quarters · filed 2021-11-01 | $70.06M 10-Q · filed 2021-11-01 | $73.71M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-06-30 | -$68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $70.08M 10-Q · filed 2021-08-11 | $73.72M derived: sum of 3 quarters · filed 2022-04-01 | $75.16M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-03-31 | $70.14M 10-Q · filed 2021-05-04 | $73.79M derived: sum of 2 quarters · filed 2022-04-01 | $75.22M derived: sum of 3 quarters · filed 2022-04-01 | $109.00M derived: sum of 4 quarters · filed 2022-04-01 |
| 2020-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | $5.08M derived: sum of 2 quarters · filed 2022-04-01 | $38.86M derived: sum of 3 quarters · filed 2022-04-01 | $40.40M 10-K · filed 2022-04-01 |
| 2020-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $35.21M derived: sum of 2 quarters · filed 2021-11-01 | $36.75M 10-Q · filed 2021-11-01 | $43.46M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $33.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $35.32M 10-Q · filed 2021-08-11 | $42.03M derived: sum of 3 quarters · filed 2021-08-11 | $41.75M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $1.54M 10-Q · filed 2021-05-04 | $8.25M derived: sum of 2 quarters · filed 2021-05-04 | $7.97M derived: sum of 3 quarters · filed 2021-05-04 | $7.00M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $6.43M derived: sum of 2 quarters · filed 2021-03-03 | $5.46M derived: sum of 3 quarters · filed 2021-03-03 | $74.64M 10-K · filed 2021-03-03 |
| 2019-09-30 | -$277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$1.25M derived: sum of 2 quarters · filed 2020-11-02 | $67.93M 10-Q · filed 2020-11-02 | $66.58M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | -$971.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $68.21M 10-Q · filed 2020-08-04 | $66.85M derived: sum of 3 quarters · filed 2020-08-04 | $66.45M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $69.18M 10-Q · filed 2020-05-14 | $67.83M derived: sum of 2 quarters · filed 2020-05-14 | $67.42M derived: sum of 3 quarters · filed 2020-05-14 | $97.18M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$1.76M derived: sum of 2 quarters · filed 2020-03-02 | $28.01M derived: sum of 3 quarters · filed 2020-03-02 | $98.91M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$408.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $29.36M derived: sum of 2 quarters · filed 2019-10-30 | $100.26M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $29.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $100.67M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $70.90M 10-Q · filed 2019-05-02 |